#PatientsEU2024
Patients as Partners Europe Demonstrated:
• How pharma and biotech companies can have a fully integrated approach to patient engagement
• An understanding on what the highest impact activities are to speed up medicine development
• Embedding patient engagement, diversity and access early in clinical research
• Multicultural aspect of patient engagement programs
• Collaboration, transparency and partnerships
Why now?
It is essential to understand how patient involvement in clinical research can accelerate medicine development, how it can improve better access, inclusivity and diversity. The medicine development community is figuring out how patient data is being used and must find solutions to return data back to patients. The R&D industry is also grappling with an understanding of how patient involvement can help advance sustainable clinical development? It is important to demonstrate the value of patient engagement in clinical trials and to know what’s on the regulatory landscape.
Experts from Sanofi, GSK, Boehringer Ingelheim, Lundbeck, Novartis, Pfizer, Ipsen, AstraZeneca, Roche and more gathered with patient advocacy to address:
• The future of patient informed research
• Understanding patient preferences and decentralized clinical trials
• Advancing health equity and diversifying clinical trials to engage underserved communities
• The patient experience data landscape and returning patient data
• Turning patient insights into action
• Mapping and how to measure patient engagement
• Patient burden-reducing solutions and technologies
• Regulatory requirements and patient engagement in drug development
Co-Chair
Victoria DiBiaso
Sanofi
Co-Chair
Alfred Samuels
Patient Advocate
Co-Chair
Nichola Gokool
Parexel
2024 Co-Chairs
2024 Keynotes and Featured Speakers
Keynote
Emma Lawton,
Patient Advocate
Keynote
Sarah Zenner Dolan,
Patient Advocate
Andrew Garvey,
Global Patient Advocacy Lead,
GSK
Patrick Gallogly,
Medical Advisor,
Pfizer
Anders Lassen,
Senior Director, Patient Insights,
Lundbeck
Annie Gilbert,
Global Patient Advocacy Lead
Boehringer Ingelheim
Sally Dews, Director, Global Patient Advocacy and External Partnerships
Pfizer UK
Lisa Kerr,
Senior Director, R&D Patient Science,
AstraZeneca
Patients as Partners® Multimedia Resources
Editorials:
Bi-monthly interviews with industry leaders in patient engagement.
Podcasts:
Monthly discussions expanding on conference topics.
Webcasts:
Live and on-demand video sessions on timely topics.
What to Expect
The 8th annual #PatientsEU2024 conference offered an unparalleled opportunity to hear from pharma R&D and patient advocacy together on how patient involvement gets done to drive greater efficiencies in clinical research with better outcomes. The conference prioritized the patient voice for the R&D industry to learn how we can move into the next phase of patient centricity to better support access and decision-making for patients, increase diverse representation to connect with a wide range of patient communities, and how this transformation will make finding clinical research easier for patients and allow for faster and more efficient clinical development.
Patients First!
Thanks to patients, we have the following patient initiatives in place:
• Patient advisory groups to gain their input on the program agenda
• Patients have a wide choice of speaking opportunities
• Dedicated patient-led sessions, panels and roundtables
• Patients in clinical trials registration scholarship program covering 100% of the attendees registration fee
Additional Program Features
Interactive Sessions
Face-To-Face Networking Breaks
Meet Exhibiting Companies Supporting Patient-Centered Medicine Development